Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8548847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro inhibition of murine IFN gamma production by phosphorothioate deoxyguanosine oligomers.

  1995cited by this paper
• Effects of IL-12 on helper T cell-dependent immune responses in vivo.

  1994cited by this paper
• The molecular cell biology of interferon-gamma and its receptor.

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

  1993cited by this paper
• Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

  1993cited by this paper
• Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

  1993cited by this paper
• Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

  1992cited by this paper
• Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production.

  1992cited by this paper
• Oligonucleotide Sequences Required for Natural Killer Cell Activation

  1992cited by this paper
• DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth

  1992cited by this paper
• Synthetic Oligonucleotides with Particular Base Sequences from the cDNA Encoding Proteins of Mycobacterium bovis BCG Induce Interferons and Activate Natural Killer Cells

  1992cited by this paper
• DNA Binding to Mouse Cells is Mediated by Cell-Surface Molecules: The Role of These DNA-Binding Molecules as Target Antigens in Murine Lupus

  1992cited by this paper
• Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

  1991cited by this paper
• Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli

  1991cited by this paper
• Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

  1991cited by this paper
• Characterization of oligonucleotide transport into living cells.

  1989cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989cited by this paper
• Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

  1989cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

  1987cited by this paper
• Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells.

  1986cited by this paper
• DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA.

  1985cited by this paper
• Recombinant interferon-gamma increases HLA-DR synthesis and expression.

  1983cited by this paper
• Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon.

  1983cited by this paper
• Interferon treatment of NZB mice: accelerated progression of autoimmune disease

  1978cited by this paper

• An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection.

  2022cites this paper
• CpG-Containing Oligodeoxynucleotides and Freund Adjuvant in Combination with Alum Augment the Production of Monoclonal Antibodies Against Recombinant HBsAg

  2022cites this paper
• CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update

  2021cites this paper
• The role of bacterial DNA containing CpG motifs in diseases

  2021cites this paper
• Activation of Innate Immunity by Therapeutic Nucleic Acids

  2021cites this paper
• TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation

  2020cites this paper
• The Central Role and Possible Mechanisms of Bacterial DNAs in Sepsis Development

  2020cites this paper
• Bioinspired nucleic acid structures for immune modulation.

  2019cites this paper
• The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.

  2019cites this paper
• A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice

  2018cites this paper
• Stimulatory effect of Aggregatibacter actinomycetemcomitans DNA on proinflammatory cytokine expression by human gingival fibroblasts.

  2017cites this paper
• Radiation‐enhanced delivery of systemically administered amphiphilic‐CpG oligodeoxynucleotide

  2017cites this paper
• Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

  2016cites this paper
• Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer

  2016cites this paper
• Toll like receptor mediated immune stimulation can be visualized in vivo by [18F]FDG-PET.

  2016cites this paper
• Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway

  2016cites this paper
• Allergen Immunotherapy: Vaccine Modification.

  2016cites this paper
• Immune modulation of T regulatory cells and IgE responses in horses vaccinated with West Nile virus vaccine combined with a CpG ODN.

  2015cites this paper
• Rôle de l'ADN dans l'activation du TLR9 lors de l'infection par Leishmania major : propriétés des séquences génomiques et implication des facteurs protéiques

  2014cites this paper
• Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.

  2014cites this paper
• Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.

  2014cites this paper
• TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease

  2014cites this paper
• Hyperresponsiveness in Mice IL-5, Eosinophilic Inflammation, and Airway Immunostimulatory DNA Sequences Inhibit

  2013cites this paper
• Impact of cryoablation on tumor immunity

  2013cites this paper
• Immunomodulatory Activity of Lactococcus lactis A17 from Taiwan Fermented Cabbage in OVA-Sensitized BALB/c Mice

  2013cites this paper
• Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.

  2012cites this paper
• CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma

  2012cites this paper
• Increases in GroES and GroEL from Lactobacillus acidophilus L-92 in response to a decrease in medium pH, and changes in cytokine release from splenocytes: Transcriptome and proteome analyses.

  2012cites this paper
• Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model

  2012cites this paper
• Effects of adjuvants on IgG subclasses elicited by virus-like Particles

  2012cites this paper
• Intradermal cytosine-phosphate-guanosine treatment reduces lung inflammation but induces IFN-γ-mediated airway hyperreactivity in a murine model of natural rubber latex allergy.

  2011cites this paper
• Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy.

  2011cites this paper
• Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy

  2011cites this paper
• TLR-based immune adjuvants.

  2011cites this paper
• Systemic and Local Vaccination against Breast Cancer with Minimum Autoimmune Sequelae

  2011cites this paper
• Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

  2011cites this paper
• T Helper Cytokine Responses Induced by Nasal Immunization with Glucosyltransferase-I of Streptococcus sobrinus

  2011cites this paper
• Pivotal Role of ADP-ribosylation Factor 6 in Toll-like Receptor 9-mediated Immune Signaling*

  2011cites this paper
• CpG-free plasmid DNA prevents deterioration of pulmonary function in mice.

  2010cites this paper
• Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.

  2010cites this paper
• Cytokine content in lymphoid and white adipose tissues after repeated CpG oligodeoxynucleotide administration in trained rats.

  2010cites this paper
• Optimised electroporation mediated DNA vaccination for treatment of prostate cancer

  2010cites this paper
• Effect of double-stranded DNA on maturation of dendritic cells in vitro.

  2010cites this paper
• CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.

  2009cites this paper
• Improvements in the Prevention and Treatment of Anthrax Infection

  2009cites this paper
• Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis

  2009cites this paper
• Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety

  2009cites this paper
• DNA vaccines against influenza viruses.

  2009cites this paper
• P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant

  2009cites this paper
• The role of CpG in DNA vaccines

  2009cites this paper
• Pre-priming: a novel approach to DNA-based vaccination and immunomodulation

  2009cites this paper
• Innovative strategies for co-delivering antigens and CpG oligonucleotides.

  2009cites this paper
• DNAs from Brucella strains activate efficiently murine immune system with production of cytokines, reactive oxygen and nitrogen species.

  2009cites this paper
• Mechanisms of immune stimulation by bacterial DNA

  2009cites this paper
• CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies.

  2009cites this paper
• Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell‐Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice

  2009cites this paper
• Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken.

  2009cites this paper
• Current prospects for mRNA gene delivery.

  2009cites this paper
• Virus-like particle vaccines and adjuvants: the HPV paradigm

  2009cites this paper
• Activation of skin dendritic cells by immunostimulatory DNA

  2009cites this paper
• A single-dose combination therapy that both prevents and treats anthrax infection.

  2009cites this paper
• Inductive and suppressive networks regulate TLR9‐dependent gene expression in vivo

  2009cites this paper
• Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

  2008cites this paper
• Vaccine-Induced B Cell Memory Effect of CpG Oligonucleotides on

  2008cites this paper
• In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.

  2008cites this paper
• Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.

  2008cites this paper
• Synthetic oligonucleotides as modulators of inflammation

  2008cites this paper
• Clinical application of CpG-, non-CpG-, and antisense oligodeoxynucleotides as immunomodulators.

  2008cites this paper
• Effect of CpG Oligonucleotides on Vaccine-Induced B Cell Memory1

  2008cites this paper
• Functional alterations of liver innate immunity of mice with aging in response to CpG‐oligodeoxynucleotide

  2008cites this paper
• Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.

  2008cites this paper
• A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.

  2008cites this paper
• Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.

  2007cites this paper
• Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.

  2007cites this paper
• Impact of class A, B and C CpG‐oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus‐1 infected individuals

  2007cites this paper
• INCORPORATION OF CpG OLIGODEOXYNUCLEOTIDES INTO α2-MACROGLOBULIN: DEVELOPMENT OF A NOVEL VACCINE ADJUVANT DELIVERY MECHANISM

  2007influential citation
• ff ects of CpGB ODN on the protein expression profile of swine

  2007cites this paper
• Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy

  2007cites this paper
• Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear

  2007cites this paper
• REVIEW ARTICLE: The Role of Toll‐Like Receptor Ligands/Agonists in Protection Against Genital HSV‐2 Infection

  2007cites this paper
• PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.

  2007cites this paper
• Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals.

  2007cites this paper
• Effects of CpG-B ODN on the protein expression profile of swine PBMC.

  2007cites this paper
• Strong immunostimulatory activity of AT‐oligodeoxynucleotide requires a six‐base loop with a self‐stabilized 5′‐C…G‐3′ stem structure

  2006cites this paper
• The importance of the F4 receptor in post-weaned pigs In eliciting F4 specific immune responses in the intestine

  2006cites this paper
• Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.

  2006cites this paper
• Protection against Heterologous Burkholderia pseudomallei Strains by Dendritic Cell Immunization

  2006cites this paper
• Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion.

  2006cites this paper
• Toll-like receptors and innate immunity

  2006cites this paper
• Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

  2006cites this paper
• Phagocytosis of N-acetyl-D-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-alpha, but not IL-10, production.

  2006cites this paper
• CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine

  2006cites this paper
• Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage.

  2006cites this paper
• Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha.

  2006influential citation
• Adjuvant Activity of CpG Oligodeoxynucleotides

  2006cites this paper
• Proteins involved in binding and cellular uptake of nucleic acids

  2006cites this paper
• Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.

  2006cites this paper
• CpG Oligonucleotides Improve the Protective Immune Response Induced by the Licensed Anthrax Vaccine

  2006cites this paper
• Construction, Characterization and Immunogenicity of Human Immunodeficiency Virus-Like Particles

  2005cites this paper
• Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.

  2005cites this paper